date:Apr 27, 2012
control points and increased insulin sensitivity, it was trademarked under the name Emulin.
Animal and human studies
The pair then commissioned Eurofins to conduct a study in 2007 on diabetic rats treated with Emulin, who showed sharp reductions in fasting, two hour postprandial, and area under the curve (AUC) blood glucose, claimed Thompson.
This was then followed by a human study at The Diabetic and Glandular Disease Clinic in San Antonio, Texas, on 40 adults with type 2 diabetes and a BMI of